Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
MicroPort NeuroScientificHKSE:02172 -1.37%93 Return-on-Tangible-Equity is 12.32% as of Dec. 2025, which is 14% below its 10-year median of 14.38. GuruFocus rates HKSE:02172 with a GF Score™ of 93/100 and a GF Value™ of HK$13.19 (Possible Value Trap). The stock has 3 warning signs investors should review. Among 758 Medical Devices & Instruments companies, MicroPort NeuroScientific ranks better than 71.77% on this metric.
Return-on-Tangible-Equity is calculated as Net Income divided by its average total shareholder tangible equity. Total shareholder tangible equity equals to Total Stockholders Equity minus Intangible Assets. MicroPort NeuroScientific's annualized net income for the quarter that ended in Dec. 2025 was HK$202.4 Mil. MicroPort NeuroScientific's average shareholder tangible equity for the quarter that ended in Dec. 2025 was HK$1,642.7 Mil. Therefore, MicroPort NeuroScientific's annualized Return-on-Tangible-Equity for the quarter that ended in Dec. 2025 was 12.32%.
The historical rank and industry rank for MicroPort NeuroScientific's Return-on-Tangible-Equity or its related term are showing as below:
HKSE:02172'
s Return-on-Tangible-Equity Range Over the Past 10 Years
Min: -4.31 Med: 14.38 Max: 76.5
Current: 12.39
During the past 7 years, MicroPort NeuroScientific's highest Return-on-Tangible-Equity was 76.50%. The lowest was -4.31%. And the median was 14.38%.
HKSE:02172's Return-on-Tangible-Equity is ranked better than 71.77% of 758
companies
in the Medical Devices & Instruments industry
Industry Median: 4.15
vs HKSE:02172: 12.39
Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.
Be Aware
Net Income is used.
Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.
MicroPort NeuroScientific Return-on-Tangible-Equity Related Terms
MicroPort NeuroScientific Return-on-Tangible-Equity Historical Data
* Premium members only.
The historical data trend for MicroPort NeuroScientific's Return-on-Tangible-Equity can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
HKSE:02172 vs ABT, SYK, MDT: Return-on-Tangible-Equity Comparison
For the Medical Devices subindustry, MicroPort NeuroScientific's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
MicroPort NeuroScientific Return-on-Tangible-Equity vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, MicroPort NeuroScientific's Return-on-Tangible-Equity distribution charts can be found below:
* The bar in red indicates where MicroPort NeuroScientific's Return-on-Tangible-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is two times the semi-annual (Dec. 2025) net income data.
Return-on-Tangible-Equity is displayed in the 10-year financial page.
What does a Return-on-Tangible-Equity of 12.32% mean?
MicroPort NeuroScientific (HKSE:02172) has a Return-on-Tangible-Equity of 12.32% as of Dec. 2025. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on MicroPort NeuroScientific and its competitors. This is 14% below median its historical median of 14.38. According to the industry distribution chart, MicroPort NeuroScientific ranks #214 out of 758 companies in the Medical Devices & Instruments industry, placing it in the top 28.2%.
Is MicroPort NeuroScientific's Return-on-Tangible-Equity too high?
MicroPort NeuroScientific's current Return-on-Tangible-Equity of 12.32% is 14% below median its 10-year median of 14.38. The Medical Devices & Instruments industry median Return-on-Tangible-Equity is 4.15. MicroPort NeuroScientific's value of 12.32% is 196.9% above this industry median. Based on the distribution chart, MicroPort NeuroScientific ranks #214 out of 758 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, MicroPort NeuroScientific has a GF Score™ of 93/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does MicroPort NeuroScientific's Return-on-Tangible-Equity compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, MicroPort NeuroScientific ranks #214 out of 758 companies for Return-on-Tangible-Equity. This puts MicroPort NeuroScientific in the upper half of its industry. The industry median Return-on-Tangible-Equity is 4.15. MicroPort NeuroScientific's value of 12.32% is 196.9% above this benchmark. While the company's 10-year median is 14.38 vs. the industry median of 4.15, MicroPort NeuroScientific has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Equity for a Medical Devices & Instruments company?
The median Return-on-Tangible-Equity among Medical Devices & Instruments companies is 4.15, based on 758 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Equity significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. MicroPort NeuroScientific's current Return-on-Tangible-Equity of 12.32% is 196.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Equity mean?
A high Return-on-Tangible-Equity can signal that a stock is expensive relative to its fundamentals. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on MicroPort NeuroScientific and its competitors. For the Medical Devices & Instruments industry, the median Return-on-Tangible-Equity is 4.15 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. MicroPort NeuroScientific's current Return-on-Tangible-Equity is 12.32%, which is 14% below median its own 10-year median of 14.38. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MicroPort NeuroScientific stock overvalued right now?
Based on GuruFocus' analysis, MicroPort NeuroScientific (HKSE:02172) is currently considered Possible Value Trap. The stock's GF Value™ is HK$13.19, compared to a current price of HK$9.01 — trading 31.7% below its estimated fair value. The current Return-on-Tangible-Equity is 12.32%, which is 14% below median its 10-year median of 14.38 and 196.9% above the Medical Devices & Instruments industry median of 4.15. MicroPort NeuroScientific's overall GF Score™ is 93/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Equity calculated?
Return-on-Tangible-Equity is calculated from a company's financial statements. For MicroPort NeuroScientific (HKSE:02172), the current Return-on-Tangible-Equity is 12.32% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is MicroPort NeuroScientific (HKSE:02172) Overvalued in 2026?
Based on GuruFocus' analysis, MicroPort NeuroScientific stock appears to be undervalued.
The current stock price of HK$9.01 is trading 31.7% below its estimated GF Value™ of HK$13.19.
GuruFocus considers MicroPort NeuroScientific to be Possible Value Trap.
Key valuation signals for HKSE:02172:
Return-on-Tangible-Equity: 12.32% (14% below median its 10-year median of 14.38)
GF Value™: HK$13.19 vs. price of HK$9.01 (31.7% below fair value)
Industry Position: 196.9% above the Medical Devices & Instruments median (#214 of 758)
No single metric tells the full story. See the HKSE:02172 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
MicroPort NeuroScientific Corp is in the neuro-interventional medical device industry, dedicated to providing solutions for physicians and patients. The company boasts a comprehensive portfolio of approved therapeutic products covering all of three main areas of neurovascular disease, namely hemorrhagic stroke, cerebral atherosclerotic stenosis, and acute ischemic stroke. The company generates almost all of its revenue from the sale of medical devices. Geographically, the company generates the majority of its revenue from the PRC region, and also has operations in Israel.
93GF Score
Get the complete analysis for HKSE:02172
Return-on-Tangible-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:02172 has been successfully added to your 
